ABASSI, Z., KOTOB, S., PIERUZZI, F., ABOUASSALI, M., KEISER, H. R., FRATANTONI, J. C., and ALAYASH, A. I. Effect of Polymerization on the hypertensive action of diaspirin crosslinked hemoglobin in rats, J. Lab. Clin. Med. 129, 603-610 . (1997).
ABURGO. O., BALAGOPALAKRISHNA C., RIFKIND J.M., RUDOLPH A.S., HESS J.R., MACDONALD V.W. (2001). Direct measurements of haemoglobin interactions with liposomes using EPR spectroscopy, Artif. Cells Blood Substit. Immobil. Biotechnol. 29(1):5-18,
ADEKOGBE I., GHANEM (2005). Fabrication and characterization of DTBP-crosslinked chitosan scaffolds for skin tissue engineering. Biomaterials, 26, 7241-7250.
AKAMA K., GONG W.-L., WANG L., TOKUYAMA S., TSUCHIDA E. (1999). Stable preservation of Hemoglobin vescicles as a blood substitute. Polymers for Advanced Technologies.10, 293-298.
ALAYASH A.I. (2004). Oxygen therapeutics: can we tame Haemoglobin? Nature. 3, 152-159.
ALLEMANN E., GURNY R., DOELKER E. (1993). Drug–loaded nanoparticles. Preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. 39, 173–191.
ALLEMANN E., LEROUX, J.–C., AND GURNY, R. (1998). Polymeric nano– and microparticles for the oral delivery of peptides and peptidomimetics. Adv. Drug Deliv. Rev. 34, 171–189.
ALLEN J.W., HASSANEIN T., BHATIA S.N. (2001). Advances in bioartificial liver devices. Hepatology. 34, 447-455.
ALTANKOV G., GRINNEL F., GROTH T. (1996). Studies on the biocompatibility of materials: fibroblast reorganization of substratum-bound fibronectin on surfaces varying in wettability. J.Biomed. Mater. Res. 30, 385-391.
AMOROSA M. (1995). in Principi di tecnica farmaceutica. Eds., Libreria Universitaria L. Tinarelli, Bologna.
ANDERSON J. M. AND SHIVE M. S. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28, 5–24.
ANGELOVA N., HUNKELER D. (1999). Rationalizing the design of polymeric biomaterials. Tibtech. 17, 409-421.
ANTONIETTI M., FORSTER S. (2003). Vesicles and Liposomes: A Self-Assembly Principle Beyond Lipids, Advanced Materials 15 (16), 1323-1333.
ARIFIN D. R. and PALMER A. F. (2005). Polymersome Encapsulated Hemoglobin: A Novel Type of Oxygen Carrier Biomacromolecules 6, 2172-2181.
ARTURSSON P., EDMAN P., LAAKSO T., AND SJOHOLM I. (1984). Characterization of polyacryl starch microparticles as carriers for proteins and drugs. J. Pharm. Sci. 73, 1507–1513.
BARBIERI R., QUAGLIA M., DELFINI M., BROSIO E. (1998). Investigation of water dynamic behaviour in poly(HEMA) and poly(HEMA-co-DHPMA) hydrogels by proton T2-relaxation time and self-diffusion coefficient NMR measurements. Polymer, 39(5), 1059.1066.
BARBUCCI R., BUSI E., MAGNANI A., FERRUTI P., RANUCCI E. AND TARAVIRAS S. (1994). Biomaterials. Chim. Ind. 76, 17–23.
BIZZARI R., CHIELLINI F., SOLARO R., CHIELLINI E., CAMMASMARION S., GUERIN P. (2002). Synthesis and characterization of new malolactonate polymers and copolymers for biomedical applications. Macromolecules. 35(4), 1215-1223.
BOS R. AND NIEWENHUIZEN W. (1992). The potential improvement of thrombolytic therapy by targeting with bispecific monoclonal antibodies: why they are used and how they are made. Biotherapy 5, 187–199.
BRIGGER I., DUBERNET C. AND COUVREUR P. (2002). Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54, 631–651.
BUEHLER W., ALAYASH I. (2004). Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems. Transfusion. 44, 1516-1530.
CARON A., MENU P., LABRUDE P., and VIGNERON C. (1998) Proposition of a technique to assess the vasoactive effects of hemoglobin-based O2 carrying solutions in vivo: preliminary results in the rabbit aorta. Artif. Cells, Blood Substitutes, Immobilization Biotechnol. 26, 293-308.
CHANG T.M.S. (1997). Blood substitutes: Principles, methods, products and clinical trials. Vol. 1, Karger, Basel,.
CHANG T. M. S. (2004). Hemoglobin-based Red Blood Cell Substitutes, Artificial Organs 28 (9):789–794.
CHARULATHA V., RAJARAM A.(2003). Influence of different crosslinking treatments on the physical properties of collagen membranes. Biometrials. 24, 759-767.
CHATTERJEE R., WELTY E. V., WALDER R. Y., PRUITT S. L., ROGERS S. L., ARNONE A., and WALDER J. A. (1986). Isolation and characterization of a new hemoglobin deri.+tive cross-linked between the alfa chains (lysine 99 alfa 1---lysine 99 alfa 2) J. Biol.Chem. 261: 9929-9937.
CHIELLINI E., LEONARDI G., GIANNASI D., SOLARO R. (1992). Partial esters of alternating copolymers of maleic anhydride and alkyl vinyl ethers for pharmaceutical applications. J. Bioact. Compat. Polym. 7(2), 161-174.
CHIELLINI E., CHIELLINI E.E., CHIELLINI F., SOLARO R. (2001b). Targeted administration of protein drugs. I. Preparation of polymeric nanoparticles. J. Bioact. Compat. Polym. 16(6), 441-465.
CHIELLINI E. (2001c). A new biocompatible nanoparticle delivery system for targeted release of fibrinolytic drugs – TATLYS Progetto Europeo EC GRD1-2000-25765; Contract n° G5RD-CT-2000-0294.
CHIELLINI F. (2006). Perspective on: in-vitro evaluation of biomedical polymers. Journal of Bioactive and Compatible Polymers. 21, 257-271.
CHIELLINI F., BIZZARRI R., OBER C.K., SCHMALJIOHANN D. (2001a). Patterning of polymeric hydrogels for biomedical applications. Macromol. Rapid Commun. 22(15), 1284-1287.
CHILKOTI A., DREHER M. R., MEYER D. E. AND RAUCHER D. (2002). Targeted drug delivery by thermally responsive polymers. Adv. Drug Deliv. Rev. 54, 613–630.
COUVREUR P., FATAL E. AND ANDREMONT A. (1991b). Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharm. Res. 8, 1079– 1086.
COUVREUR P., PUISIEUX F. (1993). Nano- and microparticles for the delivery of polypeptides and proteins Adv. Drug Deliv.Rev. 10, 141-162.
COUVREUR P., DUBERNET C. AND PUISIEUX F. (1995). Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur. J. Pharm. Biopharm. 41, 2– 13.
CRAIG C. R. AND STITZEL R. E. (1994). Farmacologia Moderna p. 374–377. Zanichelli IT.
DOHERTY D. H., DOYLE M. P., CURRY S. R., VALI R. J., FATTOR T. J., OLSEN J. S., and LEMON D. D. (1998). Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin, Nat. Biotechnol. 1, 672-676.
DRABKIN D.L., AUSTIN J.H..(1935). Spectrophotometric studies II. Preaparations from washed blood cells; nitric oxide hemoglobin and sulfhemoglobin. J.Biol.Chem. 112, 51-65.
DRURY J.L., MOONEY D.J., (2004). The tensile properties of alginate hydrogels. Biomaterials. 25, 3187-3199.
EDHOLM O., NORDLANDER P., CHEN W., OHLSSON P.I., SMITH M.L., PAUL J. (2000). The effect of water on Fe3+/Fe2+ reduction potential of heme. Biochemical and Biophysical Research Communication. 268, 683-687.
EL-GIBALY I., ANWAR M. (2004). Hemolysate-filled polyethyleneimine and polyurea microcapsules as potential red blood cell substitutes: effect of aqueous monomer type on properties of the prepared microcapsules, International Journal of Pharmaceutics 278, 25– 40,
FAHLVIK A.K., ARTUSSON P., EDMAN P. (1990).Magnetic starch microspheres: Interactions of a microsphere MR contrast medium with macriphages in vitro. Int. J. Pharm, 65, 249-259
FAMBRI L. (2002) in Integrated Biomaterials Science Barbucci, R. (Ed.), p. 129, Kluwer Academic/ Plenum Publishers, New York, NY.
FERNANDES A., GREGORIADIS G.(1997). Polysialyated asparaginase : preparation, activity and pharmacokinetics. Biochim. Biophys. Acta. 1341, 26-34.
FESSI H., PUSIEUX F., DEVISSAGUET J.P., AMMOURY N., BENITA S.(1989) Nanocapsules formation by interfacial polymer depositino following solvent displacement. Int. J. Pharm. 55.
FOURNIER R. L. (1999). Basic Transport Phenomena in Biomedical Engineering. Taylor & Francis, Philadelphia.
FRANCIS G. E. AND DELGADO C. (2000). Drug Targeting. Strategies, Principles, and Applications. Humana Press, Totwa, NJ.
FULLER R.A., ROSEN J.A. (1986). The promise of tissue engineering. Scientific American, 280(4), 37-43.
GALLO J. M., HUNG C. T. AND PERRIER D. G. (1984). Analysis of albumin microspheres preparation. Int. J. Pharm. 22, 63–74.
GARCIA O., BLANCO D., CRUZ M.E.M., ALONSO M.J. (1997). Effect of the crosslinking with 1,1,1-trimethylolpropane trimethacrylate on 5-fluorouracil release from poly(2-hydroxyethyl methacrylate) hydrogels. Polym. Bull. 38, 55-62.
GASPAR M. M., BLANCO D., CRUZ M. E. M. AND ALONSO M. J. (1998). Formulation of L–asparaginase–loaded poly(lactide–co–glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. J. Control. Rel. 52, 53–62.
GATTI A. M. AND KNOWLES J. C. (2002). Biocompatibility and biological tests in Integrated Biomaterials Science, Barbucci, R. (Ed.), p. 793–813, Kluwer Academic/ Plenum Publisher, New York, NY.
GOMBOTZ W.R., WEE S.F.. (1998). Protein release from alginate matrices. Advanced Drug Delivery Reviews. 31, 267-285.
GOORHA BRIG YK, MAJ PRABAL DEB, LT COL T CHATTERJEE, Col PS DHOT, BRIG RS PRASAD, (2003). VSM Artifical Blood, Medical Journal Armed Forces India (MJAFI); 59, 45-50.
GOULD S. A., MOORE E. E., HOYT D. B., BURCH J. M., HAENEL J. B., GARCIA J., DE WOSKIN R., and MOSS G. S. (1998). The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergency surgery, J. Am. Coll. Surg. 187, 113-122.
GOVENDER T., RILEYT., STOLNIK S., GARNETT M. C., ILLUM L. AND DAVIES S. S. (2000a). PLA–PEG nanoparticles for site specific delivery: drug incorporation studies. J. Control. Rel. 64, 269–347.
GREF R., MINAMITAKE Y., PERACCHIA M. T., TRUBETSKOY V., TORCHILIN V. AND LANGER R. (1994). Biodegradable long–circulating polymeric nanospheres. Science 263, 1600–1603.
GREF R., DOMB A., QUELLEC P., BLUNK T., MULLER R. H., VERBAVATZ J. M. AND LANGER R. (1995). The controlled intravenous delivery of drugs using PEG– coated sterically stabilized nanospheres. Adv. Drug Deliv. Rev. 16, 215–233.
GRIFFITH L.G. (2002). Emerging design principles in biomaterials and scaffolds for tissue engineering. Ann. N.Y. Acad. Sci. 961, 83-95.
GRINNEL F., FELD M.K.(1982). Fibronectin adsorption on hydrophilic and hydrophobic surfaces detected by antibody binding and analyzed during cell adhesion in serum-containing medium. J.Biol.Chem. 257, 4888-4893.
GURNY R., PEPPAS N.A., HARRINGTON D.D., BANKER G.S. (1981). Development of biodegradable and injectable latices for controlled release of potent drugs Drug Dev. Ind. Pharm. 7, 1-25.
HAWLEY A. E., ILLUM L. AND DAVIES S.S. (1997). Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm. Res. 14, 657–661
HELLER J., BAKER R.W., GALE R.M., RODIN J.O. (1978). Controlled drug release by polymer dissolution. Partial esters of maleic anhydride copolymers-properties and theory. J. Appl. Polym. Sci. 22(7), 1991-2009.
HELLER J. (1984). Biodegradable polymers in controlled drug delivery Crit. Rev. Ther. Drug Carr. Syst. 1(1), 39-90.
HILL A. (1910). The possible effects of the aggregation of the molecules of haemoglobin on its oxygen dissociation curve. J.Physiol. 40, IV-VII.
HIREMATH S.R.R. AND HOTA A. (1999). Nanoparticles as drug delivery systems. Indian J. Pharm. Sci. 61, 69–75
HORBET T.A., SCHWAY M.B., RATNER B.D. (1984). Hydrophilic-hydrophobic copolymer as cell substrates; effect on 3T3 cell growth rates. J. Coll. Inter. Sci. 104, 28-39.
HORBET T.A., SCHWAY M.B.(1988). Correlations between mouse 3T3 cell spreading and serum fibronectin adsorption on glass and hydroxyethylmethacrylate-ethylmethacrylate copolymers. J. Biomed. Mater. Res. 22, 763-793.
HUBBEL J.A. (1999) Bioactive Biomaterials. Curr.Opin.Biotech. 10, 123-129.
IKADA Y. (2002) in Integrated Biomaterials Science Barbucci, R. (Ed.), p. 2-12, Kluwer Academic/ Plenum Publishers, New York, NY.
ISO 10993 [EN 30993] Part 10993-1 to 18, Biological compatibility of medical devices. Part 5. tests for cytotoxicity: in vitro methods, International Organisation of
IWASHITA Y. (1991). Pyridoxalated hemoglobin-polyoxyethylene conjugate (PHP) as an O2 carrier, Artif. Organs Today 1, 89-114.
KAEFFER B., BENARD C., LAHAYE M., BLOTTIERE H.M., CHERBUT C. (1999). Biological properties of ulvan, a new source of green seaweed sulphated polysaccharides on cultured normal and cancerous colonic epithelial cells. Planta Medica. 65, 527-531.
KASPER S. M., WALTER M., GRUNE F., BISCHOFF A., ERASMI H., and BUZWLLO. (1996). W. Effect of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery, Cardiovasc. Anesth. 83, 921-927.
KIRKPATRICK, C.J. and DEKKER, A. (1992). Quantitative evaluation of cell interaction with biomaterials in-vitro. Biomaterial Tissue Interfaces, p 31.
KOHN J., LANGER R., RATNER B.D., HOFFMAN A.S., SCHOEN F.J. AND LEMONS J.E. (1996) in Biomaterials science. Eds. Academic Press, San Diego, CA (U.S.A.), 64-73.
KREUTER J. (1991). Nanoparticles-based drug delivery systems J. Controll.Rel. 16, 169-176.
KREUTER, J. (1994). Nanoparticles in Colloidal Drug Delivery Systems, Kreuter, J. (Ed.), p. 219–342, Marcel Dekker, Inc., New York, NY
KUBIAK C., MANIL L. AND COUVREUR P. (1988). Sorbtive properties of antibodies onto cyanoacrylic nanoparticles. Int. J. Pharm. 41, 181–187.
KULKARNI A., SOPPIMATH K., AMINABHAVI T., DAVE A., MEHTA M. (2000). Glutaraldehyde crosslinked sodium alginate beads containing liquid pesticide for soil application. Journal of Controlled Release. 63, 97-105.
LAHAYE M., & M.A.V. AXELOS. (1993). Gelling properties of water-soluble polysaccharides from proliferating marine green seaweeds. Carbohydrate Polymers. 22, 261-265.
LAHAYE M., INIZAN F., VIGOUROUX. (1998). NMR analysus of the chemical structure of ulavan and ulvan-boron complex formation. Carbohydrate Polymers. 36, 239-249.
LAHAYE M., CIMADEVILLA E., KUHLENKAMP R., QUEMENER B., LOGNONE V., DION P. (1998). Chemical composition and 13C NMR spectroscopic characterisation of ulvans from Ulva (Ulvales, Chlorophya). Journal of Applied Phycology. 00:, 1-7.
LAMPRECHT A., UBRICH N., PEREZ M. H., LEHR C.M., HOFFMAN M. AND MAINCENT P. (2000). Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int. J. Pharm. 196, 177–182.
LANGER R., VACANTI J. (1993). Tissue engineering. Science. 260, 920-926.
LANGER R. (1998). Drug delivery and targeting Nature. 392(6679), 5-10.
LEVY, M. C., RAMBOURG P., LEVY J., POTRON G. (1982). Micro-encapsulation IV: Cross-linked hemoglobin microcapsules J. Pharm. Sci. 71, 759–762.
LI Y.P., PEI Y.Y., ZHANG X.Y., GU Z.H., ZHOU Z.H., YUAN W.F., ZHOU J.J., ZHU J.H., GAO X.J. (2001). PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J. Control. Rel. 71, 203–211.
MASSIA S.P., HUBBEL J.A. (1991). An RGD spacing of 440 nm is sufficient for integrin alpha V betha 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J.Cell Biol. 114, 1089-1100.
MARCONI W. AND PIOZZI A. (2002). Structure and properties of polymeric materials. In Integrated Biomaterials Science, Barbucci, R. (Ed.), p. 25–26, Kluwer Academic/ Plenum Publisher, New York, NY.
MARTY J. J., OPPENHEIM R.C. AND SPEISER P. (1978). Nanoparticles, a new colloidal drug delivery system. Pharm. Acta Helv. 53, 17–23.
MASSIA S.P., HUBBEL J.A (1991). An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for local contact and stress fiber formation. J. Cell Biol, 114, 1089-1100.
MEADE S., MILLER A., GERRARD A. (2003). The role of dicarbonyl compounds in non-enzymatic crosslinking: a structure-Activity study. Bioorganic & Medicinal Chemistry. 11, 853-862.
MENG F. T., MA G. H., LIU Y. D., QIU W., SU Z.G. (2004). Microencapsulation of bovine hemoglobin with high bio-activity and high entrapment efficiency using a W/O/W double emulsion technique, Colloids and Surfaces B: Biointerfaces 33, 177–183.
MONCADA S., PALMER R. M. J., and HIGGS E. (1991).A. Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 43, 109-131.
MURRAY J. A., LEDLOW A., LAUNSPACH J., EVANS D., LOVEDAY M., and CONKLIN J. L. (1995). The effects of recombinant human hemoglobin on esophageal motor function in humans, Gastroenterology 109, 1241-1248.
NAGABABU E., SOMASUNDARAN R., RIFKIND J. M., Jia Y. & ALAYASH A. I. (2002).Site-specific crosslinking of human and bovine hemoglobins differentially alters oxygen binding and redox side reaction producing rhombic heme and heme degradation.Biochemistry 41, 7407–7415.
NIKOLOVSKI J., MOONEY D.J. (2000). Smooth muscle cell adhesion to tissue engineering scaffolds. Biomaterials. 21(20), 2025-2032.
PALMER T. N., CARIDE V. J., CALDECOURT M. A., TWICKLER J. AND ABDULLAH V. (1984). The mechanism of liposome accumulation in infarction. Biochim. Biophys. Acta 797, 363–368.
PARADOSSI G., CAVALIERI F., PIZZOFERRATO L., LIQUORI A.M.. (1999). A physico-chemical study on the polysaccharide ulvan from hot water extractionof the macroalga Ulva. International Journal of Biological Macromolecules. 25, 309-315.
PARADOSSI G., CAVALIERI F., CHIESSI E. (2002). A conformational study on the algal polysaccharide ulvan. Macromolecules. 35, 6404-6411.
PARK T. G., LEE H. Y. AND NAM Y. S. (1998). A new preparation method for protein loaded poly(DL–lactic–co–glycolic acid) microspheres and protein release mechanism study. J. Control. Rel. 55, 181–191.
PATTON J.N., PALMER A.F. (2006). Physical properties of Hemoglobin-poly(acrylamide) Hydrogel-Based Oxygen Carriers: Effect of Reaction pH. Langmuir 22, 2212-2221.
PATTON J.N., PALMER A.F. (2005). Engineering temperature-sensitive hydrogel nanoparticles entrapping haemoglobin as a novel type of oxygen carrier. Biomacromolecules. 6, 2204-2212.
PEPPAS N.A., LANGER R. (1994). New challenges in biomaterials. Science. 263, 1715-1720.
PERACCHIA M. T., GREF R., MINAMITAKE Y., DOMB A., LOTAN N. AND LANGER R. (1997). PEG–coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics. J.
PIETRABISSA R. (1996) in Biomateriali per Protesi e Organi Artificiali, p. 128-129, Patron Editore Bologna.
PIRAS A.M., (2006). PhDThesis “Polymeric Micro/Nanoparticles and Electrospun Fibers in Regenerative Medicine Applications” University of Pisa.
PRZYBELSKI R. J., DAILYE. K., and BIRNBAUM M. L. (1997). The pressor effect of hemoglobin - good or bad?, Advances in Blood Substitutes: Industrial Opportunities and Medical Challenges (R. M. Winslow, K. D. Vandegriff, and M. Intaglietta, Eds.) Birkhauser, Boston.
QUINTANAR–GUERRERO D., ALLEMANN E., FESSI, H. AND DOELKER E. (1998). Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers. Drug Dev. Ind. Pharm. 24, 1113–1128.
RAJAONARIVONY M., VAUTHIER C., COUARRAZE G., PUISEUX F. AND COUVREUR P. (1993). Development of a new drug carrier made from alginate. J. Pharm. Sci. 82, 912–917.
RANNEY D.F. (2000). Biomimetic transport and rational drug delivery. Biochem. Pharmacol. 59, 105–114
RATNER B.D. (1985) in Encyclopedia of polymer science and engineering. H. F. MARK, N. BIKALES, C. G. OVERBERGER and G. MENGES, Eds., Wiley-Interscience, New York.
REDHEAD H.M., DAVIS S.S. AND ILLUM L. (2001). Drug delivery in poly(lactide– co–glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Rel. 70, 353–363.
REFOJO M.F., (1969) Artificial membranes for corneal surgery. J.Biomed. Mater. Res. 3(2), 333-347.
RIESS J. G. (2001).Oxygen carriers (‘blood substitutes’) Raion d’etre, chemistry, and some physiology, Chem. Rev. 101, 2797–2894.
ROGERS B., YAKOPSON V., TENG Z., GUO Y., REGAN R. (2003). Heme oxygenase-2 knockout neurons are less vulnerable to hemoglobin toxicity. Free Radical Biology & Medicine. 35, 872-881.
ROLLAND A., BOUREL D., GENETET B. AND VERGE R.L. (1987). Monoclonal antibodies covalently coupled to polymethacrylic nanoparticles: in vitro targeting to human T lymphocytes. Int. J. Pharm. 39, 173–180.
SAETTONE M.F. (1998) in Polymers in Medicine III: Biomedical and Pharmaceutical Application. C MIGLIARESI, L: NICOLAIS, P. GIUSTI and E. CHIELLINI, Eds., Elsevier, Amsterdam, 209-224.
SAKAI H., HORINOUCHI., MASADA Y., TAKEOKA S., IKEDA E. (2004). Metabolism of Hemoglobin-vescicles (artificial oxygen carriers) and their influence on organ functions in a rat model. Biomatrerials, 25, 4317-4325.
SAKUMA S., HAYASHI M. AND AKASHI M. (2001). Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv. Drug Deliv. Rev. 47, 21– 37.
SAXENA R., WIJNHOUD A. D., CARTON H., HACKE W., KASTE M., PRZYBELSKY R. J., STERN N., and KOUDSTAAL P. J. (1999). Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke, Stroke 30, 993-996.
SALTZMAN W.M., OLBRICHT W.L. (2002). Building drug delivery into tissue engineering. Nature Reviews.
polymer microspheres. In Microparticulate Systems for the Delivery of Proteins and Vaccines, Cohen, S. and Bernstein, H. (Eds.), Marcel Dekker, New York, NY.
SEFTON M.V. AND BROUGHTON R.L. (1982). Microencapsulation of erythrocytes. Biochim. Biophys. Acta 717(3), 473–477.
SEGURA T., ANDERSON B., CHUNG P.H., WEBBER R.E., SHULL K.R., SHEA D. (2005). Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials 26(4), 359-71.
SOPPIMATH K.S., AMINABHAVI T.M., KULKARNI A.R. AND RUDZINSKI W.E. (2001). Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Rel. 70, 1–20.
STADIE W.C. (1920). A method for the determination of methemoglobin in whole blood. J.Biol.Chem. 41, 237.
STELLA B., ARPICCO S., PERACCHIA M.T., DESMAELE D., HOEBEKE J., RENOIR M., D'ANGELO J., CATTEL L. and COUVREUR P. (2000). Design of folic acid–conjugated nanoparticles for drug targeting. J. Pharm. Sci. 89, 1452–1464.
STOLNIK S., DUNN S.E., GARNETT M.C., DAVIES M.C., COOMBES A.G.A., TAYLOR D.C., IRVING M.P., PURKISS S.C., TADROS T.F., DAVIES S.S. and ILLUM L. (1994a). Surface modification of poly(lactide–co–glycolide) nanospheres by biodegradable poly(lactide)–poly(ethylene glycol) copolymers. Pharm. Res. 11, 1800– 1808.
STOLNIK S., FELUMB N.C., HEALD C.R., GARNETT M.C., ILLUM L. AND DAVIES S.S. (1997). Adsorption behaviour and conformation of selected poly(ethylene oxide) copolymers on the surface of a model colloidal drug carrier. Colloids Surf. A. 122, 151–159.
conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. Biochim. Biophys. Acta 1514, 261–279.
TABATA Y. AND IKADA Y. (1989). Synthesis of gelatin microspheres containing interferon. Pharm. Res. 6, 422–427.
TERAMURA Y., KANAZAWA H., SAKAI H., TAKEOKA S. and TSUCHIDA E. (2003). Prolonged Oxygen-Carrying Ability of Hemoglobin Vesicles by Coencapsulation of Catalase in Vivo, Bioconjugate Chem. 14, 1171-1176.
THEEUWESS F., WONG P. AND YUM S. I. (1991). Encyclopedia of Pharmaceutical Technology, vol. 4, Marcel Dekker Inc, New York, NY.
TORCHILIN V.P., ZHOU F. AND HUANG L. (1993). PH–Sensitive liposomes. J. Liposome Res. 3, 201–255.
TOROCK E’., POLLOK J.-M., MA P.X., VOGEL C., DANDRI M., PETRSEN J., BURDA M.R., KAUFMANN P.M., KLUTH D., ROGIERS X. (2001). Digestive Surgery. 18, 196-203.
UCHEGBU I.F. AND VYAS S.P. (1998). Non–ionic surfactant vesicles (niosomes) in drug delivery. Int. J. Pharm. 172, 33–70.
UCHIDA T., YAGI A., ODA Y., NAKADA Y. AND GOTO S. (1996). Instability of bovine insulin in poly(lactide–co–glycolide) (PLGA) microspheres. Chem. Pharm. Bull. 44, 235–236.
UHRICH K.E. (1999). Polymeric systems for controlled drug release Chem. Rev. 99, 3181-3198.
VACANTI J. (1988). Beyond transplantation: the third annual Samuel Jason Mixter Lecture. Arch. Sung. 123, 545-551.
VAN VACHEM P.B., HOGT A.H., BEUGELING T., FEIJEN J., BANTJES A., DETMERS J.P., VAN-AKEN W.G. (1985). Interaction of cultured human endothelial cells with polymeric surfaces of different wettabilities. Biomaterials. 6, 403-408.
VASIR J. K., REDDY M. K. and LABHASETWAR V. D. (2005). Nanosystems in Drug Targeting: Opportunities and Challenges, Current Nanoscience 1, 47-64.
VERONESE F.M. AND CALICETI P. (2002). Drug Delivery Systems. In Integrated Biomaterials Science, Barbucci, R. (Ed.), p. 833–873, Kluwer Academic/ Plenum Publishers, New York, NY.
VERRECCHIA T., SPENLEHAUER G., BAZILE D.V., MURRY–BRELIER A., ARCHIMBAUD Y. AND VEILLARD M. (1995). Non–stealth (poly(lactic acid/ albumin)) and stealth (poly(lactic acid/ polyethyliene glycol)) nanoparticles as injectable drug carriers. J. Control. Rel. 36, 49–61.
VILA A., SANCHEZ A., TOBIO M., CALVO P. AND ALONSO M. J. (2002). Design of biodegradable particles for protein delivery. J. Control. Rel. 78, 15–24.
WANG X., MORI T., SUMII T., LO E. (2002). Hemoglobin-induced cytotoxicity in rat cerebral cortical neurons. Stroke. July 2002, 1882-1888.
WEBER C., COESTER C., KREUTER J., LANGER K.(2000). Desolvatation process and surface characterisation of protein nanoparticles. International journal of Pharmaceutics, 194, 91-102.
WILEMAN T.E.(1991) Propreties of Asparaginas-dextran conjugates. Adv. Drug Delivery Rev. 6, 167-180.
WILLIAMS D.F. (1987). Definitions in Biomaterials. Proceedings of a Consensus Conference of the European Society for Biomaterials, Chester, England, March 3–5 1986, vol. 4, Elsevier, Amsterdam, NL
WILLIAMS A.S., CAMILLERI J.P., GOODFELLOW R.M. AND WILLIAMS B.D. (1996). A single intra–articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen–induced arthritis. Br. J. Rheumatol. 35, 719– 724.
WRIGHT R. O., MAGNANI B., SHANNON M. W. and WOOLF A. D. (1996). N-Acetylcysteine Reduces Methemoglobin in Vitro, Ann. of Emergency Med. 28, 499-503.
YAMAMOTO A., MISHIMA S., MARUYAMA N., SUMITA M. (2000). Quantitative evaluation of cell attachment to glass, polystyrene, and fibronectin or collagen-coated polystyrene by measurement of cell adhesive shear force and cell detachment energy. J. Biomed. Mater. Res. 50, 114-124.
YEOM C.K., LEE K.-H. (1997). Vapor permeation of ethanol-water mixtures using sodium alginate membranes with crosslinking gradient structure. Journal of Membrane Science. 135, 225-235.
ZAMBAUX M.F., BONNEAUX F., GREF R., DELLACHERIE E. AND VIGNERON C. (1999). Preparation and characterization of protein C–loaded PLA nanoparticles. J. Control. Rel. 60, 179–188.
ZIJLSTRA W.G., BUURSMA A., MEEUWSEN-VAN DER ROEST W.P. (1991). Absorption Spectra of human fetal and adult oxyhemoglobin, de-oxyemoglobin, carboxyhemoglobin, and methemoglobin. Clin. Chem. 37/9, 1633-1638.
